Delivery Order SPE2DR25D6028-SPE2DR26FASTF
Award Date 12/15/25
Potential Completion Date 12/16/25
Potential Value $1.2K
Federal Agency
Awardee
Ultimate Awardee
Not listed NAICS Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency awarded a delivery order valued at $1,367.56 to AmerisourceBergen Drug Corp for QUVIVIQ 25 mg tablets (30-count supply) on August 11, 2025, with an ultimate completion date of August 12, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and represents a continuation of the vendor's established pharmaceutical supply relationship with the federal government. The product will be delivered to the place of performance in...
- The Defense Logistics Agency awarded a $1,274.00 delivery order to AmerisourceBergen Drug Corp on July 28, 2025, for the supply of Quviviq 50 mg tablets (30-count). This firm fixed price delivery order, with an ultimate completion date of July 29, 2025, represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical. The contract was competitively awarded with no set-aside designation and will be performed at the vendor's corporate office...
- The Defense Logistics Agency awarded a $2,274.96 firm fixed price delivery order to AmerisourceBergen Drug Corp for 30 tablets of Quviviq 50 mg on November 25, 2025, with an ultimate completion date of November 26, 2025. The award is unclassified with no set-aside designation and represents a competitive award to the pharmaceutical distributor headquartered in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA...
- The Defense Logistics Agency awarded a $1,356.74 delivery order to AmerisourceBergen Drug Corp on November 28, 2025, for the supply of Quviviq 25 mg tablets (30-count units). This is a firm fixed-price, non-set-aside contract with performance in Conshohocken, Pennsylvania, and a completion deadline of December 1, 2025. The delivery order falls under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a $999,999,999.00 comprehensive global...
- This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract, valued at $1,528.80, is for the delivery of QUVIVIQ 50 MG TABLET 30S, a specialty medication. The contract has an ultimate completion date of January 17, 2025. AmerisourceBergen Drug Corp is a large, for-profit pharmaceutical distribution company that plays a critical role in supplying medical...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on November 20, 2025, for the supply of Quviviq 50 mg tablets (30-count packages) under a firm fixed-price contract with a ceiling value of $1,480.08. This non-competitive delivery order is due for completion by November 21, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The contract represents a single-unit procurement of this pharmaceutical product...
- This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The $1,081.69 Firm Fixed Price Delivery Order is for the supply of 4566178485 QUVIVIQ 50 MG TABLET 30S, with a period of performance through October 23, 2024. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range of...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 22, 2025, for the supply of Quviviq 50 mg tablets (30-count packaging) under a firm fixed-price contract valued at $2,705.59, with completion targeted for August 25, 2025. This delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which carries a maximum value of $999,999,999.00 and extends...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 26, 2025, for the supply of Quviviq 25 mg tablets (30-count packaging) under a firm fixed-price contract valued at $1,829.63. This non-set-aside, competitively awarded delivery order is scheduled for completion by September 29, 2025, with performance taking place at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. The award represents a continuation of the company's role as a...
- The Defense Logistics Agency awarded a delivery order valued at $1,283.67 to AmerisourceBergen Drug Corp for QUVIVIQ 25 mg tablets (30-count) on July 21, 2025, with an ultimate completion date of July 22, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. QUVIVIQ is a prescription medication used in the treatment of insomnia, representing...